Follow
Bilal Ahmad
Title
Cited by
Cited by
Year
A structure-based drug discovery paradigm
M Batool, B Ahmad, S Choi
International journal of molecular sciences 20 (11), 2783, 2019
5612019
Exploring the binding mechanism of PF-07321332 SARS-CoV-2 protease inhibitor through molecular dynamics and binding free energy simulations
B Ahmad, M Batool, Q Ain, MS Kim, S Choi
International journal of molecular sciences 22 (17), 9124, 2021
1002021
Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
M Shah, B Ahmad, S Choi, HG Woo
Computational and Structural Biotechnology Journal 18, 3402-3414, 2020
732020
Oceans as a source of immunotherapy
B Ahmad, M Shah, S Choi
Marine drugs 17 (5), 282, 2019
332019
Origanum vulgare L.: in vitro assessment of cytotoxicity, molecular docking studies, antioxidant and anti-inflammatory activity in LPS stimulated RAW 264.7 cells
RH Mir, G Sawhney, R Verma, B Ahmad, P Kumar, S Ranjana, A Bhagat, ...
Medicinal Chemistry 17 (9), 983-993, 2021
212021
Sequence variation of SARS-CoV-2 spike protein may facilitate stronger interaction with ACE2 promoting high infectivity
M Shah, B Ahmad, S Choi, HG Woo
152020
Structural and functional characterization of the Vindoline biosynthesis pathway enzymes of Catharanthus roseus
B Ahmad, A Banerjee, H Tiwari, S Jana, S Bose, S Chakrabarti
Journal of Molecular Modeling 24, 1-14, 2018
122018
Design, Synthesis, Molecular Modelling, and Biological Evaluation of Oleanolic Acid-Arylidene Derivatives as Potential Anti-Inflammatory Agents
MHM Reyaz Hassan Mir, Goutami Godavari, Nasir Ali Siddiqui, Bilal Ahmad ...
Drug Design, Development and Therapy 15, 385—397, 2021
92021
Hedgehog antagonist pyrimidine–Indole hybrid molecule inhibits ciliogenesis through microtubule destabilisation
H Khatra, PP Khan, S Pattanayak, J Bhadra, B Rather, S Chakrabarti, ...
ChemBioChem 19 (7), 723-735, 2018
82018
Computational-driven epitope verification and affinity maturation of TLR4-targeting antibodies
B Ahmad, M Batool, MS Kim, S Choi
International Journal of Molecular Sciences 22 (11), 5989, 2021
72021
Unraveling the tomaralimab epitope on the toll-like receptor 2 via molecular dynamics and deep learning
B Ahmad, S Choi
ACS omega 7 (32), 28226-28237, 2022
62022
Therapeutic targeting of innate immune receptors against SARS-CoV-2 infection
M Farooq, AW Khan, B Ahmad, MS Kim, S Choi
Frontiers in pharmacology 13, 915565, 2022
62022
Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics
RH Pirzada, B Ahmad, N Qayyum, S Choi
Frontiers in Endocrinology 14, 542, 2023
32023
Arteannuin-B and (3-Chlorophenyl)-2-Spiroisoxazoline Derivative Exhibit Anti-Inflammatory Effects in LPS-Activated RAW 264.7 Macrophages and BALB/c Mice-Induced Proinflammatory …
G Sawhney, JU Rasool, D Saroch, M Ozturk, F Brombacher, B Ahmad, ...
Molecules 27 (22), 8068, 2022
32022
Accelerated NLRP3 inflammasome-inhibitory peptide design using a recurrent neural network model and molecular dynamics simulations
B Ahmad, A Achek, M Farooq, S Choi
Computational and Structural Biotechnology Journal 21, 4825-4835, 2023
12023
Phytochemical profiling, antioxidant, cytotoxic, and anti-inflammatory activities of Plectranthus rugosus extract and fractions: in vitro, in vivo, and in silico approaches
RH Mir, R Mohi-Ud-Din, LA Al-Keridis, B Ahmad, N Alshammari, M Patel, ...
Inflammopharmacology, 1-14, 2024
2024
Neuroinflammation, autoinflammation, splenomegaly and anemia caused by bi-allelic mutations in IRAK4
S Cooray, F Price-Kuehne, Y Hong, E Omoyinmi, A Burleigh, KC Gilmour, ...
Frontiers in Immunology 14, 1231749, 2023
2023
Nlrp3 inflammasome inhibitory peptide for treatment of inflammatory diseases
RBA Choi Sangdun
WO Patent WO2022225330A1, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18